High Mesothelin Rates May Be Good for Mesothelioma Patients
Mesothelioma patients who have higher levels of mesothelin have better survival rates. This is the finding of a new study out of Australia. Mesothelin Proteins Mesothelin is a type of protein found in mesothelioma cancer cells. Mesothelioma is a rare type of cancer that develops from cells of the mesothelium, the lining that covers many of the internal organs of the body. It is caused by exposure to a toxic mineral called asbestos. Typically, mesothelioma requires aggressive treatments to stop the cancer from growing and spreading. Such treatments may include surgery, chemotherapy, radiation therapy, or some combination. Scientists aren’t sure what mesothelin does in cancer cells. But since mesothelin is only found in cancer cells, it could be a target … Continue reading High Mesothelin Rates May Be Good for Mesothelioma Patients
Mesothelioma Response to Immunotherapy
A new study published in Frontiers in Immunology shows that doctors may be able to tell which patients with malignant pleural mesothelioma will respond better to immunotherapy. If doctors can tell which patients will benefit from immunotherapy, they can create better treatment plans for this aggressive type of cancer. Treatment Options Malignant pleural mesothelioma (MPM) is a cancer that develops in the lining of the lungs. It is caused by asbestos and is tough to treat. MPM is a rare cancer, and the standard therapies are limited. This usually involves surgery, radiation, and chemotherapy. Mesothelioma patients can move from one type of treatment to another and, if their doctors agree, can sometimes use them in combination. Even with treatment, the … Continue reading Mesothelioma Response to Immunotherapy
Creating an American Mesothelioma Patient Registry
Researchers from the University of Maryland are testing if the United States can create a mesothelioma patient registry. Other countries like Australia and Italy have created mesothelioma registries. These databases help scientists to understand how common mesothelioma is in their country. It also identifies risk factors for developing the disease. Tracking the Disease Mesothelioma is a rare cancer that affects the lining of organs such as the chest, lungs, heart, and abdomen. It is primarily caused by exposure to asbestos. Asbestos is a fibrous mineral that is used in construction and manufacturing industries. Despite being a rare disease, it has been a big public health issue, especially in the United States. Nearly 3,000 individuals are diagnosed each year. A mesothelioma … Continue reading Creating an American Mesothelioma Patient Registry
Involving Patients in Mesothelioma Research
Involving patients and the public in mesothelioma research can help scientists to make meaningful breakthroughs. A group of researchers from the United Kingdom spoke with twenty-three mesothelioma researchers. They wanted to get their opinions on how helpful it would be to involve patients and the public in their mesothelioma research. The researchers also ran online workshops and interviews to get the thoughts of patients and members of the public. Doing Meaningful Mesothelioma Research Mesothelioma is a rare form of cancer caused by asbestos exposure. It develops on the lining of internal organs like the lungs or abdominal cavity. There are about 2,000 cases of mesothelioma diagnosed in the United States each year. Doing research on mesothelioma and effective treatments can … Continue reading Involving Patients in Mesothelioma Research
The Future of Mesothelioma Research
Mesothelioma is an aggressive cancer that isn’t researched as often as other types of cancer. A new study from the European Journal of Oncology Nursing explored what questions we still need to answer to provide the best care for mesothelioma patients. Screening and Preventative Tests Malignant mesothelioma is one of the rarest cancers in the US. That is fortunate because the cancer death rates from this malignancy continue to be very high. About 3,000 people receive a mesothelioma diagnosis every year – about 0.02% of all US cancer cases. Most newly diagnosed mesothelioma patients die within 18 months of diagnosis. Since mesothelioma is so rare, there isn’t as much research on this disease compared to more common cancers. This can … Continue reading The Future of Mesothelioma Research
Scientists Find New Way To Treat Mesothelioma
Scientists Find New Way To Treat Mesothelioma Scientists think they can find new ways to treat mesothelioma by looking at its genetic makeup. The genetic changes and interactions between cancer cells and their environment could hold the key to new therapies. This is the hope of a group of scientists from Italy who published their ideas in the International Journal of Molecular Sciences. Mesothelioma Tumor and Cancer Genetics Malignant pleural mesothelioma is a cancer caused by exposure to asbestos. One reason it is hard to treat is because it doesn’t have specific genetic targets like other types of cancer. The area around the mesothelioma tumor also makes it hard to treat. The environment around the tumor affects how the tumor … Continue reading Scientists Find New Way To Treat Mesothelioma
Surgical Treatment Options for Mesothelioma
For some patients with mesothelioma, aggressive surgical treatment can help them live longer than other treatment options. This is the finding of a study published in the Journal of Thoracic and Cardiovascular Surgery. The authors focused on a specific type of surgery called “cytoreductive surgery” that is done in both the chest and belly area. Surgery Provides Hope for Cure Mesothelioma is a deadly cancer caused by asbestos exposure. The type of treatment for mesothelioma depends on many factors. The location of the cancer, the type of mesothelioma, and the health of the patient are some of these key factors. For patients who are healthy enough, surgery provides the best hope for a cure. Cytoreductive surgery is a type of … Continue reading Surgical Treatment Options for Mesothelioma
New Resource on Mesothelioma Genomics
The MESOMICS project is the most comprehensive dataset of mesothelioma genomics to date. The data in this resource can help researchers to design precision treatments for mesothelioma patients This project was created by an international collaboration between scientists from France, Chile, and the United States. Understanding Diagnosis Malignant pleural mesothelioma is a rare cancer caused by asbestos exposure. There are approximately 2,000 cases of mesothelioma diagnosed in the United States alone every year. Because it is so rare, the treatment options are very limited compared to other types of cancer. The limited treatment options combined with the cancer’s ability to spread without being noticed makes mesothelioma a deadly disease. Median overall survival for mesothelioma patients is a little over a … Continue reading New Resource on Mesothelioma Genomics
New Drug in the Pipeline for Mesothelioma
Researchers in Iran tested the safety of a new version of the drug pemetrexed in patients with non-small cell lung cancer and malignant pleural mesothelioma. This drug is used to treat these patients when they are not able to get surgery for their cancer. The researchers were able to determine that pemetrexed is safe in patients with non-squamous non-small cell lung cancer. Treatment Choices Malignant pleural mesothelioma is a lung-related cancer like non-small cell lung cancer. It is caused by exposure to asbestos. Treatment for mesothelioma usually involves chemotherapy, radiation therapy, and surgery. Patients may receive more than one type of treatment. This is called multimodal therapy. Pemetrexed is a chemotherapy drug that interrupts the cell replication process that helps … Continue reading New Drug in the Pipeline for Mesothelioma
Immune Checkpoint Inhibitors to Treat Mesothelioma
A new study supports the use of immune checkpoint inhibitors to treat malignant pleural mesothelioma. The study authors caution that immune checkpoint inhibitors should be used carefully because they can be an expensive treatment. Immunotherapy for Mesothelioma Mesothelioma is a rare type of cancer that is caused by exposure to asbestos. It develops from cells of the mesothelium, the lining that covers many of the internal organs of the body. There are approximately 2,000 cases of mesothelioma diagnosed in the United States every year. Since mesothelioma is so rare, standard treatment options are limited. Standard therapies include chemotherapy, radiation, and surgery. If more than one of these therapies is used, it may be called multimodal therapy. Immunotherapy has emerged in … Continue reading Immune Checkpoint Inhibitors to Treat Mesothelioma
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
Get your free copy of
“Surviving Mesothelioma” Today!